Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy


Ozbasar D., Toros U., Ozkaya O., SEZİK M., Uzun H., Genc H., ...More

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, vol.36, no.1, pp.133-137, 2010 (SCI-Expanded) identifier identifier identifier

Abstract

Aim: